Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: A randomized double blind clinical trial

Current treatment of non‐alcoholic fatty liver disease

(2022) Rafael Paternostro et al.   JOURNAL OF INTERNAL MEDICINE

Physiopathology of nonalcoholic fatty liver disease: from diet to nutrigenomics

(2022) Paola Meneghel et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Therapies for non-alcoholic fatty liver disease: A 2022 update

(2022) Katie Shen et al.   World Journal of Hepatology

The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double‐blind clinical trial

(2021) Reza Goodarzi et al.   PHYTOTHERAPY RESEARCH

Pomegranate as a source of bioactive constituents: a review on their characterization, properties and applications

(2020) Maryam Pirzadeh et al.   CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION

Association of the dietary patterns with the risk of non-alcoholic fatty liver disease among Iranian population: a case-control study

(2020) Narges Dehghanseresht et al.   Nutrition Journal

Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges

(2019) Úrsula Martínez-Garza et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial

(2018) Antonio González-Sarrías et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease

(2018) Mario Masarone et al.   Oxidative Medicine and Cellular Longevity

Sensitivity and Specificity of Plasma ALT, ALP, and Bile Acids for Hepatitis in Labrador Retrievers

(2017) K. Dirksen et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Effects of endurance and endurance–strength exercise on biochemical parameters of liver function in women with abdominal obesity

(2016) Damian Skrypnik et al.   BIOMEDICINE & PHARMACOTHERAPY

Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients

(2016) M Ghavipour et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications

(2016) Sven M. Francque et al.   JOURNAL OF HEPATOLOGY

Pomegranate extract and exercise provide additive benefits on improvement of immune function by inhibiting inflammation and oxidative stress in high-fat-diet-induced obesity in rats

(2016) Fei Zhao et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation

(2016) Maryam Noori et al.   JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE

Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: A randomized controlled clinical trial

(2016) Banafshe Hosseini et al.   Complementary Therapies in Clinical Practice

Effects of Pomegranate and Orange Juice on Antioxidant Status in Non-Alcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial

(2015) Golnaz Ekhlasi et al.   INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH

Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD

(2015) Takeshi Inagaki   Frontiers in Endocrinology

Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial

(2015) Yu Qin et al.   PLoS One

Mitochondrial Dysfunction in Obesity-Associated Nonalcoholic Fatty Liver Disease: The Protective Effects of Pomegranate with Its Active Component Punicalagin

(2014) Xuan Zou et al.   ANTIOXIDANTS & REDOX SIGNALING

Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding

(2013) Laura Folini et al.   ACTA DIABETOLOGICA

Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways

(2013) Jia Xiao et al.   EUROPEAN JOURNAL OF NUTRITION

The effects of caloric restriction on Fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial

(2012) Kyung Mook Choi et al.   CLINICAL ENDOCRINOLOGY

Increased Fetuin-A Concentrations in Impaired Glucose Tolerance with or without Nonalcoholic Fatty Liver Disease, But Not Impaired Fasting Glucose

(2012) Horng-Yih Ou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pomegranate: a fruit that ameliorates metabolic syndrome

(2012) Svjetlana Medjakovic et al.   Food & Function

Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss

(2010) Johanna Maria Brix et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile

(2010) Zhuofeng Lin et al.   PLoS One

Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss

(2008) Thomas Reinehr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production

(2008) Anita M. Hennige et al.   PLoS One